Einav Vax
Impact in
- Hepatology top 10%
-
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Renal and related cancers 7
-
- Renal cell carcinoma treatment 4
- Co-authors
- Charles A. Dinarello (2 shared papers)Shai Shemesh (2 shared papers)Yehuda Kamari (2 shared papers)Aviv Shaish (2 shared papers)Dror Harats (2 shared papers)Shahar Dotan (2 shared papers)Ron N. Apte (2 shared papers)Iris Barshack (5 shared papers)
- Journals
- Stem Cell Reports (2 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)Journal of Hepatology (1 paper)Oncogenesis (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
Einav Vax
13 papers receiving 559 citations
Peers
Comparison fields: 5 of 71
- Hepatology 72
- Epidemiology 212
- Immunology 126
- Molecular Biology 303
- Cell Biology 50
Countries citing papers authored by Einav Vax
This map shows the geographic impact of Einav Vax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einav Vax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einav Vax more than expected).
Fields of papers citing papers by Einav Vax
This network shows the impact of papers produced by Einav Vax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einav Vax. The network helps show where Einav Vax may publish in the future.
Co-authors
The 25 scholars most cited alongside Einav Vax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 240 | |
| 2 | 2011 | 81 | |
| 3 | 2013 | 49 | |
| 4 | 2016 | 40 | |
| 5 | 2014 | 35 | |
| 6 | 2018 | 25 | |
| 7 | 2016 | 25 | |
| 8 | 2017 | 22 | |
| 9 | 2014 | 21 | |
| 10 | 2017 | 17 | |
| 11 | 2019 | 6 | |
| 12 | 2020 | 1 | |
| 13 | 2025 | 1 |
About Einav Vax
Einav Vax is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Epidemiology, having authored 13 papers that have together received 563 indexed citations. Recurring topics across this work include Renal and related cancers (7 papers), Renal cell carcinoma treatment (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), NF-κB Signaling Pathways (2 papers), Atherosclerosis and Cardiovascular Diseases (1 paper), Renal Diseases and Glomerulopathies (1 paper) and Ethics and Legal Issues in Pediatric Healthcare (1 paper). The work is most often cited by research in Hepatology (72 citations), Epidemiology (212 citations), Immunology (126 citations), Molecular Biology (303 citations) and Cell Biology (50 citations). Einav Vax has collaborated with scholars based in Israel and United States. Frequent co-authors include Charles A. Dinarello, Shai Shemesh, Yehuda Kamari, Aviv Shaish, Dror Harats, Shahar Dotan, Ron N. Apte, Iris Barshack, Michal Kandel-Kfir and Yaron Arbel. Their work appears in journals such as Stem Cell Reports, Molecular Cancer Therapeutics, Scientific Reports, Journal of Hepatology and Oncogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.